

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08720623 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.06208590 |
| 3 | vocalization behavior (GO:0071625) | 5.87896303 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.86441122 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.72755825 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.66764441 |
| 7 | glutamate secretion (GO:0014047) | 5.65263476 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.54358435 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.45816783 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.36300590 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.23229014 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.11867880 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.08078162 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05857796 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.05831020 |
| 16 | protein localization to synapse (GO:0035418) | 5.04614372 |
| 17 | L-amino acid import (GO:0043092) | 4.82468620 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.76573915 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.76412716 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.74999605 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.70325713 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.67723569 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.61570050 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.58743005 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.42238400 |
| 26 | amino acid import (GO:0043090) | 4.36503142 |
| 27 | potassium ion homeostasis (GO:0055075) | 4.34985343 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.28095191 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.27991269 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.25674238 |
| 31 | cellular sodium ion homeostasis (GO:0006883) | 4.23052150 |
| 32 | potassium ion import (GO:0010107) | 4.22624880 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 4.19701688 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 4.18314756 |
| 35 | exploration behavior (GO:0035640) | 4.17299414 |
| 36 | positive regulation of membrane potential (GO:0045838) | 4.11705865 |
| 37 | presynaptic membrane assembly (GO:0097105) | 4.08797884 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 4.08145218 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.06809540 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 4.03519723 |
| 41 | cell communication by electrical coupling (GO:0010644) | 4.02870384 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.02509388 |
| 43 | positive regulation of dendritic spine development (GO:0060999) | 4.00253176 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.00009451 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.98328034 |
| 46 | long-term memory (GO:0007616) | 3.93989740 |
| 47 | postsynaptic membrane organization (GO:0001941) | 3.92798873 |
| 48 | presynaptic membrane organization (GO:0097090) | 3.90905156 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.88669060 |
| 50 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.87312557 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.84095978 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.80140096 |
| 53 | neuronal ion channel clustering (GO:0045161) | 3.79125495 |
| 54 | neurotransmitter transport (GO:0006836) | 3.73871250 |
| 55 | central nervous system myelination (GO:0022010) | 3.73449716 |
| 56 | axon ensheathment in central nervous system (GO:0032291) | 3.73449716 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.72293322 |
| 58 | * regulation of synaptic plasticity (GO:0048167) | 3.70137642 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.67046033 |
| 60 | auditory behavior (GO:0031223) | 3.65896343 |
| 61 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.64572571 |
| 62 | response to histamine (GO:0034776) | 3.62545549 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.59790097 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.51597322 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.50186573 |
| 66 | membrane depolarization (GO:0051899) | 3.48944151 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.48065418 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.47351954 |
| 69 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.45960817 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.44953516 |
| 71 | dendritic spine morphogenesis (GO:0060997) | 3.44655158 |
| 72 | mechanosensory behavior (GO:0007638) | 3.43073679 |
| 73 | membrane depolarization during action potential (GO:0086010) | 3.41200739 |
| 74 | neuromuscular process controlling posture (GO:0050884) | 3.39811059 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.39563778 |
| 76 | acidic amino acid transport (GO:0015800) | 3.39285594 |
| 77 | activation of protein kinase A activity (GO:0034199) | 3.37935636 |
| 78 | behavioral response to cocaine (GO:0048148) | 3.36950953 |
| 79 | proline transport (GO:0015824) | 3.36935809 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.36774042 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.32668341 |
| 82 | neuromuscular synaptic transmission (GO:0007274) | 3.31926224 |
| 83 | synaptic vesicle endocytosis (GO:0048488) | 3.30880037 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.30586276 |
| 85 | regulation of synapse maturation (GO:0090128) | 3.30477523 |
| 86 | neurotransmitter uptake (GO:0001504) | 3.29936596 |
| 87 | response to auditory stimulus (GO:0010996) | 3.29210705 |
| 88 | cerebellar Purkinje cell layer development (GO:0021680) | 3.28925737 |
| 89 | neuron recognition (GO:0008038) | 3.27667925 |
| 90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.24090122 |
| 91 | positive regulation of synaptic transmission (GO:0050806) | 3.23324363 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 3.23117591 |
| 93 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22686968 |
| 94 | regulation of vesicle fusion (GO:0031338) | 3.21792358 |
| 95 | * cerebellar Purkinje cell differentiation (GO:0021702) | 3.19405300 |
| 96 | behavioral fear response (GO:0001662) | 3.17795778 |
| 97 | behavioral defense response (GO:0002209) | 3.17795778 |
| 98 | learning (GO:0007612) | 3.17439638 |
| 99 | synaptic transmission (GO:0007268) | 3.17125171 |
| 100 | long term synaptic depression (GO:0060292) | 3.16985364 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.15972850 |
| 102 | prepulse inhibition (GO:0060134) | 3.14892413 |
| 103 | * cerebellar granule cell differentiation (GO:0021707) | 3.14825101 |
| 104 | * neuromuscular process controlling balance (GO:0050885) | 3.14589940 |
| 105 | sodium ion export (GO:0071436) | 3.13296248 |
| 106 | detection of calcium ion (GO:0005513) | 3.12276802 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.12004652 |
| 108 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11459980 |
| 109 | chemosensory behavior (GO:0007635) | 3.10812298 |
| 110 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.10739281 |
| 111 | synapse assembly (GO:0007416) | 3.10162453 |
| 112 | * regulation of synaptic transmission (GO:0050804) | 3.10058609 |
| 113 | startle response (GO:0001964) | 3.08781827 |
| 114 | vesicle docking involved in exocytosis (GO:0006904) | 3.08318217 |
| 115 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.08294946 |
| 116 | regulation of glutamate secretion (GO:0014048) | 3.07889700 |
| 117 | fear response (GO:0042596) | 3.07539979 |
| 118 | regulation of dendritic spine development (GO:0060998) | 3.07209781 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 3.06610126 |
| 120 | synaptic vesicle transport (GO:0048489) | 3.06610126 |
| 121 | dendritic spine organization (GO:0097061) | 3.05535533 |
| 122 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.05281529 |
| 123 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03256651 |
| 124 | adult walking behavior (GO:0007628) | 3.01189901 |
| 125 | axonal fasciculation (GO:0007413) | 3.01078913 |
| 126 | striatum development (GO:0021756) | 2.99123161 |
| 127 | L-glutamate transport (GO:0015813) | 2.96615866 |
| 128 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96174899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85952201 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.15504937 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19409759 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17093963 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05364137 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75804880 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70774323 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70774323 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.69009265 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62337979 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59475994 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52512513 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49801848 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49016806 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47245647 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47085347 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41854198 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36212335 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28706379 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25985244 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16424722 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14906290 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13673812 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12292540 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11627812 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05867800 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05854062 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04650255 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01394357 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94192604 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87627050 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85323494 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80933073 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78504108 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78161360 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67129240 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65593496 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54467859 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52109975 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48810628 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48106995 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47039240 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46517480 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46498384 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43619960 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41554821 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40831945 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36994353 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34150926 |
| 50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30178626 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29922223 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29227773 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28534135 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26992702 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23408965 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23088352 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22711579 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22565255 |
| 59 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22128285 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22066849 |
| 61 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22048050 |
| 62 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21923005 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20019761 |
| 64 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18867657 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18628115 |
| 66 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18390337 |
| 67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18334370 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17035347 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16743765 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16347333 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15936646 |
| 72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15497993 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14999161 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13222154 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11091324 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09505137 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09100200 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09017413 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08644449 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07391978 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06826320 |
| 82 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05375808 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04350359 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03916056 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03537578 |
| 86 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02516010 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01685586 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01257748 |
| 89 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98917808 |
| 90 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98911308 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98890393 |
| 92 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97944414 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97577825 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97428825 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96963137 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96875450 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95504401 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94492078 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94378462 |
| 100 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93829213 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92956138 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92823079 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92303034 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91285527 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90982219 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90744720 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90667403 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90667403 |
| 109 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.90245382 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89744466 |
| 111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89710184 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89567735 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89249190 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87153913 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86689108 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 0.86627483 |
| 117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86152141 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86098420 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85920753 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85196821 |
| 121 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81985312 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81581977 |
| 123 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80758606 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80023896 |
| 125 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79454041 |
| 126 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.78382119 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.78256443 |
| 128 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74957821 |
| 129 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74718281 |
| 130 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.73906324 |
| 131 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.73828986 |
| 132 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73362145 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71507516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.48630857 |
| 2 | MP0003880_abnormal_central_pattern | 5.24974635 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.31835431 |
| 4 | MP0009046_muscle_twitch | 3.80883275 |
| 5 | MP0009745_abnormal_behavioral_response | 3.73509603 |
| 6 | MP0004270_analgesia | 3.70586202 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.46423922 |
| 8 | MP0002064_seizures | 3.45214121 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.24729328 |
| 10 | MP0002822_catalepsy | 3.19208656 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 3.01382228 |
| 12 | * MP0002272_abnormal_nervous_system | 2.79086388 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.66891761 |
| 14 | MP0002736_abnormal_nociception_after | 2.60115440 |
| 15 | * MP0001486_abnormal_startle_reflex | 2.50671658 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.48879078 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.39968363 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.28887516 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.25278248 |
| 20 | * MP0002067_abnormal_sensory_capabilities | 2.17103124 |
| 21 | MP0008569_lethality_at_weaning | 2.16964661 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.09503132 |
| 23 | MP0001970_abnormal_pain_threshold | 1.94372974 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.94121972 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.84627654 |
| 26 | MP0004924_abnormal_behavior | 1.83400373 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.83400373 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.78377162 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.67853632 |
| 30 | * MP0002184_abnormal_innervation | 1.66708074 |
| 31 | MP0003329_amyloid_beta_deposits | 1.63308389 |
| 32 | MP0001984_abnormal_olfaction | 1.61676281 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.60286785 |
| 34 | MP0000778_abnormal_nervous_system | 1.54226607 |
| 35 | MP0003787_abnormal_imprinting | 1.52194357 |
| 36 | MP0003633_abnormal_nervous_system | 1.47178050 |
| 37 | MP0004858_abnormal_nervous_system | 1.46791669 |
| 38 | MP0000955_abnormal_spinal_cord | 1.45834753 |
| 39 | * MP0002066_abnormal_motor_capabilities/c | 1.44342738 |
| 40 | MP0003123_paternal_imprinting | 1.42775609 |
| 41 | MP0004142_abnormal_muscle_tone | 1.40848441 |
| 42 | * MP0003879_abnormal_hair_cell | 1.38514761 |
| 43 | MP0001529_abnormal_vocalization | 1.35956301 |
| 44 | MP0001188_hyperpigmentation | 1.33975392 |
| 45 | * MP0002882_abnormal_neuron_morphology | 1.32231683 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.30192479 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.28492158 |
| 48 | MP0004885_abnormal_endolymph | 1.24749932 |
| 49 | MP0003631_nervous_system_phenotype | 1.23044308 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.21635064 |
| 51 | MP0008872_abnormal_physiological_respon | 1.19282280 |
| 52 | MP0004147_increased_porphyrin_level | 1.17369205 |
| 53 | MP0001905_abnormal_dopamine_level | 1.12069956 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.04484945 |
| 55 | MP0003122_maternal_imprinting | 1.03338613 |
| 56 | MP0008874_decreased_physiological_sensi | 1.02796669 |
| 57 | * MP0002152_abnormal_brain_morphology | 1.02038223 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.01171699 |
| 59 | MP0002638_abnormal_pupillary_reflex | 0.98024749 |
| 60 | MP0000751_myopathy | 0.97446658 |
| 61 | MP0002069_abnormal_eating/drinking_beha | 0.93514690 |
| 62 | * MP0002229_neurodegeneration | 0.89707297 |
| 63 | MP0004085_abnormal_heartbeat | 0.89258739 |
| 64 | MP0001348_abnormal_lacrimal_gland | 0.89078674 |
| 65 | MP0000569_abnormal_digit_pigmentation | 0.87031119 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 0.86119900 |
| 67 | MP0001346_abnormal_lacrimal_gland | 0.84767168 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.84439322 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.84165414 |
| 70 | MP0001177_atelectasis | 0.83920640 |
| 71 | MP0003632_abnormal_nervous_system | 0.83502035 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.83118437 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 0.82946982 |
| 74 | MP0005535_abnormal_body_temperature | 0.81390371 |
| 75 | * MP0001963_abnormal_hearing_physiology | 0.77527254 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.77444206 |
| 77 | MP0003690_abnormal_glial_cell | 0.75331216 |
| 78 | MP0004130_abnormal_muscle_cell | 0.74753408 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.72997415 |
| 80 | MP0004484_altered_response_of | 0.72826467 |
| 81 | MP0003075_altered_response_to | 0.72173311 |
| 82 | MP0004043_abnormal_pH_regulation | 0.71678640 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.69816853 |
| 84 | MP0000604_amyloidosis | 0.68982062 |
| 85 | MP0000920_abnormal_myelination | 0.68236255 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.66168812 |
| 87 | MP0005171_absent_coat_pigmentation | 0.65679792 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.65645441 |
| 89 | MP0001664_abnormal_digestion | 0.65364043 |
| 90 | MP0003634_abnormal_glial_cell | 0.64919565 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.64770460 |
| 92 | MP0005499_abnormal_olfactory_system | 0.64272205 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.64272205 |
| 94 | * MP0002752_abnormal_somatic_nervous | 0.62594626 |
| 95 | * MP0004742_abnormal_vestibular_system | 0.58648320 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.57374326 |
| 97 | MP0003283_abnormal_digestive_organ | 0.57203705 |
| 98 | MP0001943_abnormal_respiration | 0.57141173 |
| 99 | MP0010769_abnormal_survival | 0.56685100 |
| 100 | MP0004233_abnormal_muscle_weight | 0.56317328 |
| 101 | MP0005409_darkened_coat_color | 0.56127644 |
| 102 | MP0010770_preweaning_lethality | 0.55835532 |
| 103 | MP0002082_postnatal_lethality | 0.55835532 |
| 104 | MP0004510_myositis | 0.55605317 |
| 105 | MP0002090_abnormal_vision | 0.54689151 |
| 106 | MP0010768_mortality/aging | 0.53656846 |
| 107 | MP0000579_abnormal_nail_morphology | 0.52915524 |
| 108 | * MP0003956_abnormal_body_size | 0.50538134 |
| 109 | MP0005166_decreased_susceptibility_to | 0.50058381 |
| 110 | MP0002653_abnormal_ependyma_morphology | 0.48946969 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.48339586 |
| 112 | MP0000747_muscle_weakness | 0.45406368 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.44949907 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.43947506 |
| 115 | MP0003045_fibrosis | 0.43691439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.18415932 |
| 2 | Myokymia (HP:0002411) | 6.62505847 |
| 3 | Focal seizures (HP:0007359) | 6.35713610 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.99485691 |
| 5 | Atonic seizures (HP:0010819) | 5.75582920 |
| 6 | Febrile seizures (HP:0002373) | 5.41946839 |
| 7 | Visual hallucinations (HP:0002367) | 4.99247855 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.76774597 |
| 9 | Absence seizures (HP:0002121) | 4.75624574 |
| 10 | Hyperventilation (HP:0002883) | 4.56714513 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.43574903 |
| 12 | Dialeptic seizures (HP:0011146) | 4.38090487 |
| 13 | Broad-based gait (HP:0002136) | 4.29163866 |
| 14 | Action tremor (HP:0002345) | 4.20224457 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.14248568 |
| 16 | Poor eye contact (HP:0000817) | 3.86991430 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.84681833 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.66756160 |
| 19 | Dysmetric saccades (HP:0000641) | 3.60658958 |
| 20 | Impaired social interactions (HP:0000735) | 3.45677501 |
| 21 | Abnormal social behavior (HP:0012433) | 3.45677501 |
| 22 | Tetraplegia (HP:0002445) | 3.42087480 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.39076247 |
| 24 | Obstructive sleep apnea (HP:0002870) | 3.37040721 |
| 25 | Truncal ataxia (HP:0002078) | 3.35455710 |
| 26 | Impaired smooth pursuit (HP:0007772) | 3.33768921 |
| 27 | Scanning speech (HP:0002168) | 3.30843691 |
| 28 | Dysmetria (HP:0001310) | 3.20733043 |
| 29 | Cerebral hypomyelination (HP:0006808) | 3.17364581 |
| 30 | Amblyopia (HP:0000646) | 3.13215582 |
| 31 | Depression (HP:0000716) | 3.09368970 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.08501614 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00692143 |
| 34 | Genetic anticipation (HP:0003743) | 2.93358344 |
| 35 | Anxiety (HP:0000739) | 2.92962022 |
| 36 | Abnormality of the lower motor neuron (HP:0002366) | 2.92477178 |
| 37 | Ankle clonus (HP:0011448) | 2.89085293 |
| 38 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.87185328 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.80889136 |
| 40 | Status epilepticus (HP:0002133) | 2.76384791 |
| 41 | Postural instability (HP:0002172) | 2.75826466 |
| 42 | Excessive salivation (HP:0003781) | 2.73135701 |
| 43 | Drooling (HP:0002307) | 2.73135701 |
| 44 | Akinesia (HP:0002304) | 2.70567267 |
| 45 | Hemiplegia (HP:0002301) | 2.69048979 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 2.68718185 |
| 47 | Delusions (HP:0000746) | 2.66499596 |
| 48 | Stereotypic behavior (HP:0000733) | 2.64969496 |
| 49 | Hemiparesis (HP:0001269) | 2.57469775 |
| 50 | Diplopia (HP:0000651) | 2.54210465 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.54210465 |
| 52 | Impaired vibratory sensation (HP:0002495) | 2.53633065 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52809697 |
| 54 | Annular pancreas (HP:0001734) | 2.49951786 |
| 55 | Torticollis (HP:0000473) | 2.47498364 |
| 56 | Urinary urgency (HP:0000012) | 2.43417304 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.43182472 |
| 58 | Sleep apnea (HP:0010535) | 2.42277383 |
| 59 | Bradykinesia (HP:0002067) | 2.42086625 |
| 60 | Intention tremor (HP:0002080) | 2.40703030 |
| 61 | Absent speech (HP:0001344) | 2.39381957 |
| 62 | Protruding tongue (HP:0010808) | 2.37466114 |
| 63 | Spastic gait (HP:0002064) | 2.36598898 |
| 64 | Inability to walk (HP:0002540) | 2.36013426 |
| 65 | Focal dystonia (HP:0004373) | 2.35507771 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.34906558 |
| 67 | Pheochromocytoma (HP:0002666) | 2.31460253 |
| 68 | Resting tremor (HP:0002322) | 2.29836075 |
| 69 | Progressive inability to walk (HP:0002505) | 2.29758768 |
| 70 | Apathy (HP:0000741) | 2.23974632 |
| 71 | Mutism (HP:0002300) | 2.22359943 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20088858 |
| 73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20088858 |
| 74 | Bundle branch block (HP:0011710) | 2.19780140 |
| 75 | Termporal pattern (HP:0011008) | 2.19522485 |
| 76 | Insidious onset (HP:0003587) | 2.19522485 |
| 77 | Spastic tetraparesis (HP:0001285) | 2.18897844 |
| 78 | Blue irides (HP:0000635) | 2.18515091 |
| 79 | Gait ataxia (HP:0002066) | 2.16000869 |
| 80 | Abnormality of saccadic eye movements (HP:0000570) | 2.14461368 |
| 81 | Incomplete penetrance (HP:0003829) | 2.14147409 |
| 82 | Peripheral hypomyelination (HP:0007182) | 2.13812940 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.11746300 |
| 84 | Insomnia (HP:0100785) | 2.11325298 |
| 85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.10202607 |
| 86 | Craniofacial dystonia (HP:0012179) | 2.08366491 |
| 87 | Choreoathetosis (HP:0001266) | 2.05821922 |
| 88 | Polyphagia (HP:0002591) | 2.04898850 |
| 89 | Rapidly progressive (HP:0003678) | 2.02285399 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.02198335 |
| 91 | Ventricular fibrillation (HP:0001663) | 2.02005932 |
| 92 | Abnormality of the corticospinal tract (HP:0002492) | 2.00616873 |
| 93 | Diminished motivation (HP:0000745) | 1.98354590 |
| 94 | Papilledema (HP:0001085) | 1.97875252 |
| 95 | CNS hypomyelination (HP:0003429) | 1.97720647 |
| 96 | Heart block (HP:0012722) | 1.92212585 |
| 97 | Lower limb muscle weakness (HP:0007340) | 1.89356013 |
| 98 | Limb ataxia (HP:0002070) | 1.89060467 |
| 99 | Memory impairment (HP:0002354) | 1.86735980 |
| 100 | Postural tremor (HP:0002174) | 1.85442086 |
| 101 | Pointed chin (HP:0000307) | 1.82478451 |
| 102 | Hypoventilation (HP:0002791) | 1.80524842 |
| 103 | Limb dystonia (HP:0002451) | 1.80188388 |
| 104 | Abnormality of salivation (HP:0100755) | 1.79595990 |
| 105 | Specific learning disability (HP:0001328) | 1.79389824 |
| 106 | Lower limb asymmetry (HP:0100559) | 1.76533406 |
| 107 | Gait imbalance (HP:0002141) | 1.76435458 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75458026 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75458026 |
| 110 | Aplasia involving bones of the extremities (HP:0009825) | 1.75458026 |
| 111 | Slow progression (HP:0003677) | 1.75210259 |
| 112 | Psychosis (HP:0000709) | 1.75165461 |
| 113 | Spinal canal stenosis (HP:0003416) | 1.75068017 |
| 114 | Abnormal atrioventricular conduction (HP:0005150) | 1.73283947 |
| 115 | Abnormal hair whorl (HP:0010721) | 1.71925722 |
| 116 | Increased circulating renin level (HP:0000848) | 1.71316564 |
| 117 | Lower limb amyotrophy (HP:0007210) | 1.71115746 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.69901134 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.69328265 |
| 120 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69005232 |
| 121 | Agitation (HP:0000713) | 1.68801618 |
| 122 | Generalized hypopigmentation of hair (HP:0011358) | 1.68126393 |
| 123 | Megalencephaly (HP:0001355) | 1.67417810 |
| 124 | Rigidity (HP:0002063) | 1.67261623 |
| 125 | Abnormality of the periventricular white matter (HP:0002518) | 1.66508124 |
| 126 | Cerebral inclusion bodies (HP:0100314) | 1.65647612 |
| 127 | Clonus (HP:0002169) | 1.64957510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.63843453 |
| 2 | NTRK3 | 4.40755633 |
| 3 | CASK | 3.86885901 |
| 4 | MAP3K9 | 3.31771806 |
| 5 | DAPK2 | 3.16248705 |
| 6 | MAP3K4 | 3.03427379 |
| 7 | MAP2K7 | 2.72696818 |
| 8 | CDK19 | 2.42649387 |
| 9 | MINK1 | 2.36778381 |
| 10 | MAP3K12 | 2.34451307 |
| 11 | DAPK1 | 2.19392922 |
| 12 | RIPK4 | 2.11063224 |
| 13 | CAMKK2 | 2.02012226 |
| 14 | CAMKK1 | 1.96210793 |
| 15 | MAP2K4 | 1.95287376 |
| 16 | MARK1 | 1.93770482 |
| 17 | PAK6 | 1.91911960 |
| 18 | NTRK2 | 1.83219958 |
| 19 | PRPF4B | 1.80352406 |
| 20 | PLK2 | 1.74434000 |
| 21 | KSR2 | 1.66702296 |
| 22 | KSR1 | 1.54008290 |
| 23 | CCNB1 | 1.53281672 |
| 24 | CDK5 | 1.44022617 |
| 25 | TNIK | 1.42209294 |
| 26 | NTRK1 | 1.40032761 |
| 27 | PRKD3 | 1.37667196 |
| 28 | AKT3 | 1.34251010 |
| 29 | OXSR1 | 1.29600276 |
| 30 | ARAF | 1.25713996 |
| 31 | PRKCG | 1.25612997 |
| 32 | GRK5 | 1.24242702 |
| 33 | MAPK13 | 1.19130332 |
| 34 | STK38 | 1.17929472 |
| 35 | SGK2 | 1.15923298 |
| 36 | SIK3 | 1.13696734 |
| 37 | SGK223 | 1.12522219 |
| 38 | SGK494 | 1.12522219 |
| 39 | SIK2 | 1.09413002 |
| 40 | FES | 1.01439314 |
| 41 | CAMK2A | 1.01350794 |
| 42 | MAP3K13 | 1.00261144 |
| 43 | PNCK | 0.97992460 |
| 44 | CAMK1 | 0.94936601 |
| 45 | BMPR2 | 0.93640290 |
| 46 | CDK18 | 0.92192149 |
| 47 | SGK3 | 0.89946246 |
| 48 | CAMK2B | 0.89729588 |
| 49 | MAP3K2 | 0.88593364 |
| 50 | TAOK1 | 0.87129422 |
| 51 | BRSK1 | 0.86757051 |
| 52 | CDK15 | 0.86342837 |
| 53 | STK11 | 0.85758521 |
| 54 | PTK2B | 0.84923673 |
| 55 | CDK14 | 0.78757800 |
| 56 | UHMK1 | 0.78439700 |
| 57 | TYRO3 | 0.78168930 |
| 58 | SGK1 | 0.76774505 |
| 59 | PRKCH | 0.76013718 |
| 60 | CDK11A | 0.74393601 |
| 61 | RAF1 | 0.68841471 |
| 62 | PDK1 | 0.65605523 |
| 63 | PINK1 | 0.63991377 |
| 64 | PDPK1 | 0.63777716 |
| 65 | RET | 0.61555595 |
| 66 | WNK1 | 0.60834348 |
| 67 | PKN1 | 0.60802149 |
| 68 | MAP3K11 | 0.60338602 |
| 69 | TNK2 | 0.59919694 |
| 70 | DAPK3 | 0.59624432 |
| 71 | CAMK4 | 0.59416002 |
| 72 | BRAF | 0.58447194 |
| 73 | PRKCE | 0.52202321 |
| 74 | MARK2 | 0.51928754 |
| 75 | DYRK1A | 0.50953561 |
| 76 | LIMK1 | 0.50258334 |
| 77 | PHKG2 | 0.50046964 |
| 78 | PHKG1 | 0.50046964 |
| 79 | NEK6 | 0.49864173 |
| 80 | CAMK2G | 0.48476995 |
| 81 | RPS6KA3 | 0.48155365 |
| 82 | MAP3K1 | 0.47093771 |
| 83 | RIPK1 | 0.46961992 |
| 84 | CAMK2D | 0.45684774 |
| 85 | CDC42BPA | 0.45327865 |
| 86 | FGFR2 | 0.44599504 |
| 87 | ROCK2 | 0.43546553 |
| 88 | BCR | 0.41499776 |
| 89 | CAMK1G | 0.40591840 |
| 90 | MAPK12 | 0.40130509 |
| 91 | ALK | 0.39425879 |
| 92 | CSNK1G2 | 0.39363091 |
| 93 | MAPK7 | 0.39056266 |
| 94 | MAP2K1 | 0.38849462 |
| 95 | LMTK2 | 0.37752952 |
| 96 | NEK1 | 0.37639739 |
| 97 | FYN | 0.37071262 |
| 98 | PRKCZ | 0.36065856 |
| 99 | LATS2 | 0.36007098 |
| 100 | PAK3 | 0.35620002 |
| 101 | NME1 | 0.35580732 |
| 102 | PDK3 | 0.35491078 |
| 103 | PDK4 | 0.35491078 |
| 104 | PRKG1 | 0.34992992 |
| 105 | * PRKCA | 0.34868212 |
| 106 | MAPK10 | 0.32564807 |
| 107 | PRKCB | 0.32444867 |
| 108 | MAP3K7 | 0.31509342 |
| 109 | ERBB2 | 0.26836869 |
| 110 | CSNK1D | 0.26243909 |
| 111 | PRKACA | 0.25769268 |
| 112 | TESK1 | 0.25492353 |
| 113 | PRKG2 | 0.25144825 |
| 114 | MAP2K6 | 0.24725282 |
| 115 | ROCK1 | 0.24048641 |
| 116 | MAPKAPK5 | 0.23974142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.17463389 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.66378041 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.87813106 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.86791637 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81967237 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75417496 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72628794 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.72413796 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.66339506 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.65464874 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17113452 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.13625386 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.05470451 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.01343941 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.97017226 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95558461 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87107715 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84749312 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83474103 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.82889130 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.75310111 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67701034 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66026229 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64779973 |
| 25 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63292501 |
| 26 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52721353 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37606683 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34141198 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28679977 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28444199 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.27322461 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26010056 |
| 33 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24968985 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22845675 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17633655 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16274907 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16117889 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13446193 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07023629 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05253561 |
| 41 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98184682 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97346186 |
| 43 | Glioma_Homo sapiens_hsa05214 | 0.97242941 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94970067 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93687626 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.91299029 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91029147 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.90149109 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85538907 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.81167492 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80691964 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.79065381 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78328799 |
| 54 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.76995638 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74245496 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73909987 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72129368 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70130448 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70101426 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69537706 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69454568 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64388153 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64233043 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58965797 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58833358 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58516550 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57222095 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56935104 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54675647 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51805883 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51196490 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50511286 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50249911 |
| 74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49049974 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48721568 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47985605 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44497458 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.44439642 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44180606 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.44119271 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44067269 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43289998 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40990643 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40858303 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40312861 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39612903 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39170056 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39055263 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38143309 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37508662 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36400782 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35867335 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35675109 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.35308467 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35059484 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35001543 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.32928782 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31278306 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31149461 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30877314 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30464324 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29603261 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29141276 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28669670 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27109345 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26249070 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25797760 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24659272 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22124969 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20498954 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20461944 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18106367 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.17879607 |

